Delenex Therapeutics AG is a startup based in Switzerland, most recent round Acquired, 1 tracked investor.
Delenex Therapeutics AG is a company headquartered in Switzerland. Delenex Therapeutics AG has been acquired. Brouky records 1 investor associated with the company.
Delenex Therapeutics AG was a clinical-stage biopharmaceutical company focused on developing antibody therapeutics using its proprietary PENT(R)Body platform to create potent and stable antibody fragments for treating diseases including oncology, Crohn's disease, and psoriasis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.